Siemens, BrainLab, and Boston Scientific have partnered with a company with the first FDA-approved technology that allows surgeons to see, in real-time, into a patient’s brain during any of the 2.2 million minimally-invasive neuro procedures that happen every year in the U.S.
Key Emphasis: How to Profit from Disruptive Changes in Healthcare and Finance
Immunotherapy is the new black when it comes to treating Cancer, raising hope in conquering this age old illness.
This week, we respond to a recent Wall Street Journal article documenting immunotherapy as a new treatment for Cancer. We tell you what companies they […]
Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR) recently announced that a seven year-old girl suffering from an aplastic bone marrow whose condition was rapidly deteriorating is now experiencing a reversal of her condition.
The Massachusetts based company is a worldwide developer, manufacturer and marketer of medical devices.
Gerry DiFiore, partnered with the global law firm of Reed Smith is specialized in securities law on emerging growth companies. He recently co-authored a paper on the Jobs Act.
On June 1, more than 25,000 cancer specialists will come together at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago. With ASCO hours away, we look at some small biotech companies making headway in cancer treatment.
Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.
OneMedPlace kicked off OneMedForum NY 2012 with an exclusive investor networking reception to raise awareness about the upcoming 3rd annual finance conference.
Copyright © 2025 | WordPress Theme by MH Themes